PATH | VRL
Menu

Technical Information for National-Level PCV Policy Recommendations: Summary of Available Evidence to Guide Decision-Making

This document provides high-level summaries of the best available evidence around the use of pneumococcal conjugate vaccines (PCV) in low- and middle-income countries. Designed for vaccine decision-makers, it synthesizes the evidence required to formulate decisions regarding the introduction and optimal use of PCV and includes information on pneumococcal disease, vaccine safety and efficacy, and economic considerations for the vaccine.

Author: International Vaccine Access Center

Published: 2017

» Download file (English)

3.87 MB PDF (Located at www.jhsph.edu)

Resource types: Report

Diseases/vaccines: Pneumococcus

Topics: Introduction and service delivery, Immunization financing, Disease burden and surveillance, Vaccine safety and performance, Disease/vaccine specific information

Regions: Global